Project description:We present here a genome-wide map of abnormalities found in diagnostic samples from 45 adults and adolescents with acute lymphoblastic leukemia (ALL). 500K single nucleotide polymorphism (SNP) array analysis uncovered frequent genetic abnormalities, with cryptic deletions constituting half of the detected changes, implying that microdeletions are a characteristic feature of this malignancy. Importantly, the pattern of deletions resembled that recently reported in pediatric ALL, suggesting that adult, adolescent, and childhood cases may be more similar on the genetic level than previously thought. Thus, 70% of the cases displayed deletion of one or more of the CDKN2A, PAX5, IKZF1, ETV6, RB1, and EBF1 genes. Furthermore, several genes not previously implicated in the pathogenesis of ALL were identified as possible recurrent targets of deletion. In total, the SNP array analysis identified 367 genetic abnormalities not corresponding to known copy number polymorphisms, with all but two cases (96%) displaying at least one cryptic change. This SNP array study is the first to specifically address adult and adolescent ALL, and the resolution level is the highest used to date to investigate a malignant hematologic disorder. Our findings provide insights into the leukemogenic process and may be clinically important in adult and adolescent ALL. Most importantly, we report that microdeletions of key genes appear to be a common, characteristic feature of ALL that is shared between different clinical, morphological, and cytogenetic subgroups. Keywords: Genomic analysis of acute lymphoblastic leukemia samples

2008-04-10 | GSE9611 | GEO

Homo sapiens

Project description:The absence of retroelement activity is characteristic for childhood acute leukemias and adult acute lymphoblastic leukemia

| PRJNA800807 | ENA

Homo sapiens

Project description:MicroRNA profiling in Acute Lymphoblastic Leukemia (ALL)

| PRJNA258157 | ENA

Homo sapiens

Project description:MicroRNA profiling of Acute Lymphoblastic Leukemia (ALL)

| PRJNA254713 | ENA

Homo sapiens

Project description:TARGET: Acute Lymphoblastic Leukemia (ALL) Phase II